Yeast Beta-glucan Market Size & Growth Forecast 2027–2036, By Segments (Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Yeast Beta-glucan Market size was valued at USD 243.27 million in 2026 and is anticipated to grow at a 7.79% CAGR from 2027 to 2036, attaining USD 515.08 million by 2036. The industry revenue for 2027 is assessed at USD 259.23 million.

• Base Year Value (2026): USD 243.27 million
• CAGR (2027-2036): 7.79%
• Forecast Year Value (2036): USD 515.08 million
• Historical Data Period: 2022-2026
• Largest Region: Asia Pacific
• Forecast Period: 2027-2036

Yeast Beta-glucan Market Intelligence Snapshot:

• Regional Market Dynamics:

  • Asia Pacific held a 32.40% share in 2026 due to its large functional ingredient manufacturing base and strong demand across food, beverage, nutraceutical, and feed applications.
  • Europe is projected to grow at a 9.27% CAGR, driven by stronger adoption of functional ingredients for immune support, gut health, and clean-label nutrition products.

• Segment Momentum:

  • Food & Beverages accounted for 32.4% of the market in 2026 because yeast beta-glucan is widely incorporated into functional foods and nutrition-focused products, supporting stable commercial demand.
  • Animal Feed is the fastest-growing application as producers increasingly adopt yeast beta-glucan in feed formulations that support livestock health and production efficiency.

• Market Expansion Drivers:

  • Growing functional food and animal feed applications increasing yeast beta-glucan demand.
  • Rising chronic diseases and aging population driving immune-boosting ingredient consumption.
  • Expansion of nutraceutical formulations integrating beta-glucan into mainstream dietary supplements.

• Leading Market Participants:

  Major players in the yeast beta-glucan market include Cargill, Incorporated (USA), Lesaffre Group (France), Kerry Group plc (Ireland), Lallemand Inc. (Canada), Angel Yeast Co., Ltd. (China), Leiber GmbH (Germany), Biorigin (Brazil), DSM-Firmenich AG (Netherlands), Archer Daniels Midland Company (USA), Tate & Lyle PLC (United Kingdom).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 243.27 million
  • 2027 Estimated Market Size: USD 259.23 million.
  • Projected Market Size: USD 515.08 million by 2036
  • Growth Forecasts: 7.79% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: Asia Pacific
  • High-Growth Regional Hub: Europe
  • Core Revenue Segment: Food & Beverages (Application)
  • Emerging Opportunity Segment: Animal Feed (Application)

Market Growth Drivers and Industry Trends

Growing functional food and animal feed applications increasing yeast beta-glucan demand

Broader use of functional food and animal feed products is creating additional application opportunities, supporting the yeast beta-glucan market as manufacturers incorporate functional ingredients into formulations. Increasing utilization across these applications is expanding the range of products in which beta-glucan can be included, while demand for functional attributes is encouraging greater consideration of yeast-derived ingredients. This diversification of applications is strengthening consumption across food and feed formulations.

Rising chronic diseases and aging population driving immune-boosting ingredient consumption

Growing attention to immune support amid rising chronic diseases and an aging population is contributing to demand, with the yeast beta-glucan market gaining from increased consumption of ingredients associated with immune-boosting formulations. Consumers and product manufacturers are placing greater emphasis on nutritional solutions that support health and wellness needs, encouraging the incorporation of beta-glucan into relevant food and dietary products. This shift is increasing interest in functional ingredients that can address evolving consumer health priorities.

Expansion of nutraceutical formulations integrating beta-glucan into mainstream dietary supplements

The increasing integration of beta-glucan into nutraceutical products is broadening its presence in mainstream dietary supplements and supporting the yeast beta-glucan market. Formulators are incorporating beta-glucan into supplement offerings as demand for functional and health-oriented ingredients expands beyond specialized products. Greater availability of beta-glucan-containing formulations is helping bring the ingredient into more consumer-facing supplement categories, strengthening its role within evolving nutraceutical product portfolios.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Growing functional food and animal feed applications increasing yeast beta-glucan demand	1.70%	Moderate	Asia Pacific, North America	High	Near Term
Rising chronic diseases and aging population driving immune-boosting ingredient consumption	1.90%	Moderate	North America, Europe	High	Near Term
Expansion of nutraceutical formulations integrating beta-glucan into mainstream dietary supplements	1.40%	Moderate	Asia Pacific, North America	Medium	Mid Term

Regional Demand Dynamics

Asia Pacific (Largest Region) vs Europe (Fastest-Growing Region)

In the yeast beta-glucan market, Asia Pacific held the largest share at 32.40% in 2026, supported by increasing consumer interest in functional nutrition, immune-supporting ingredients, and health-oriented food products. Growing awareness of preventive wellness is encouraging manufacturers to incorporate beta-glucan into functional foods, dietary supplements, and specialized nutrition products. The region's expanding processed food and nutraceutical industries are also creating broader application opportunities, while rising disposable incomes and changing dietary preferences are supporting demand for products positioned around health and wellness benefits. In addition, the development of food ingredient processing capabilities and greater consumer acceptance of functional ingredients are helping strengthen regional market penetration.

Europe is the fastest-growing region, driven by strong consumer awareness of nutritional health, increasing demand for functional ingredients, and a well-developed market for health-focused food and supplement products. Consumers are placing greater emphasis on preventive wellness and scientifically supported nutritional benefits, creating favorable conditions for ingredients such as yeast beta-glucan. The region's established functional food sector is encouraging manufacturers to explore formulations that support immune health and broader nutritional objectives. Regulatory attention toward food quality and ingredient standards is also promoting demand for well-characterized functional ingredients, while continued innovation in food and nutraceutical formulations is creating additional avenues for yeast beta-glucan adoption.

Key Country Insights

United States

Functional Ingredient Innovation

The U.S. yeast beta-glucan market benefits from growing demand for immune-support and functional nutrition ingredients. Manufacturers in the U.S. expand research, product development, and application across dietary supplements, food, and beverage formulations.

Japan

Preventive Health Applications

Japan incorporates yeast beta-glucan into functional foods and nutritional products aligned with preventive health trends. Ingredient suppliers in Japan emphasize product purity, formulation compatibility, and consumer confidence in scientifically supported wellness solutions.

South Korea

Nutraceutical Product Development

South Korea expands yeast beta-glucan applications across dietary supplements and functional food innovations. Manufacturers in South Korea invest in ingredient refinement and value-added formulations that respond to growing consumer interest in daily wellness products.

Germany

Science-Based Formulations

Germany prioritizes clinically supported ingredient development and quality assurance for yeast beta-glucan products. Companies in Germany focus on standardized production processes and evidence-based formulations to serve nutrition and health product manufacturers.

France

Clean Label Nutrition

France supports yeast beta-glucan adoption through demand for natural and clean-label functional ingredients. Companies in France integrate yeast-derived ingredients into health-oriented food and supplement products while maintaining high quality and traceability standards.

Italy

Functional Food Integration

Italy increasingly incorporates yeast beta-glucan into nutritional foods and wellness-focused consumer products. Ingredient suppliers in Italy collaborate with food manufacturers to develop formulations that balance health benefits, taste, and product stability.

Segment Leadership and Growth Trends

 

Application Segment Analysis: Food & Beverages (Largest Segment) vs Animal Feed (Fastest-Growing Segment)

The food & beverages segment dominated the yeast beta-glucan market, accounting for a 32.4% share in 2026. Demand is supported by growing consumer interest in functional foods and beverages that provide nutritional and wellness benefits beyond basic nourishment. Yeast beta-glucan is increasingly incorporated into formulations where its functional properties can support product differentiation and appeal to health-conscious consumers. The expansion of fortified foods, dietary products, and wellness-oriented formulations is further strengthening its role across food and beverage applications.

Animal feed represents the fastest-growing segment, driven by increasing emphasis on livestock health, nutritional efficiency, and feed quality. Yeast beta-glucan is gaining attention as a functional feed ingredient that can support animal well-being and contribute to improved nutritional management. Growing adoption of feed additives that promote healthier livestock while supporting productivity is creating additional opportunities for yeast beta-glucan. The broader shift toward value-added animal nutrition is expected to reinforce demand within this application.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Application	Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed, Others	Food & Beverages	Animal Feed

Competitive Landscape and Market Positioning

Prominent players in the yeast beta-glucan market:

1. Cargill Incorporated (USA)

2. Lesaffre Group (France)

3. Kerry Group plc (Ireland)

4. Lallemand Inc. (Canada)

5. Angel Yeast Co. Ltd. (China)

6. Leiber GmbH (Germany)

7. Biorigin (Brazil)

8. DSM-Firmenich AG (Netherlands)

9. Archer Daniels Midland Company (USA)

10. Tate & Lyle PLC (United Kingdom)

The yeast beta-glucan market is gaining momentum due to increasing awareness of functional health ingredients. In the yeast beta-glucan market, scientific research is expanding application possibilities across nutrition and wellness sectors. Collaborative development efforts are improving ingredient functionality and formulation stability. Rising demand for immune-supporting ingredients is driving broader adoption in food and supplement applications.

Industry Development/News

Company Name	Date	Key Development
Angel Yeast	Apr-25	Angel Yeast reported clinical trial findings showing that daily intake of yeast beta-glucan may support symptom improvement in mild cognitive impairment. The study expands potential applications of yeast beta-glucan beyond immune health into cognitive wellness nutraceutical formulations, strengthening its positioning in functional ingredient development.
Kemin Industries	Jun-23	Kemin Industries received Thai FDA approval for BetaVia Complete as a novel food ingredient, supporting its use in dietary supplements for immune health. The approval validates regulatory acceptance of its bioactive beta-glucan formulation and expands commercialization potential in functional nutrition markets.
Kemin Industries	Dec-22	Kemin Industries expanded its Cavriago production facility to increase manufacturing capacity for beta-glucan products used in animal nutrition and health applications. The expansion strengthens supply capabilities and supports growing demand for functional bioactive ingredients in the global nutrition market.
Angel Yeast	Dec-21	Angel Yeast initiated a large-scale yeast production expansion project targeting an annual capacity increase of 20,000 tons, scheduled for completion in May 2024. The investment strengthens its manufacturing footprint and enhances its ability to meet rising global demand for yeast-derived bioactive ingredients including beta-glucans.
Lesaffre Human Care	Jun-20	Lesaffre Human Care acquired a majority stake in Biohymn Biotechnology, a Chinese yeast and yeast extract producer, to strengthen its presence in the Chinese market. The acquisition enhances regional production capabilities and supports strategic expansion of yeast-derived ingredient offerings across Asia.